Talzenna 0.35 mg, Hartkapseln
7680671410082
CH-67141
Kapseln
Associated product:
TALZENNA caps 0.35 mg bte 30 pce
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
talazoparibum
|
0.35 MG | Substance | Wirkstoff (Principe actif) |
|
talazoparibi tosilas
|
- | Substance | WIZUS |
|
cellulosum microcristallinum silicificatum
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
lacca
|
- | Substance | HNIDK |
|
propylenglycolum
|
- | Substance | HNIDK |
|
ammonii hydroxidum
|
- | Substance | HNIDK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
kalii hydroxidum
|
- | Substance | HNIDK |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 67141
- Drug name
- Talzenna, Hartkapseln
- Galenic form
- KAPS
- ATC Code
- L01XK04
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 12/12/2019
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- TALZENNA caps 0.35 mg bte 30 pce
- Description (DE)
- TALZENNA Kaps 0.35 mg Ds 30 Stk
- Market launch
- 12/07/2024
- Narcotic (BTM)
- No